[1]
|
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A. and Haukka, J. (2009) 11-Year Fol-low-Up of Mortality in Patients with Schizophrenia: A Population-Based Cohort Study (FIN11 Study). The Lancet, 374, 620-627. https://doi.org/10.1016/S0140-6736(09)60742-X
|
[2]
|
Lawrence, D., Hancock, K.J. and Kisely, S. (2013) The Gap in Life Expectancy from Preventable Physical Illness in Psychiatric Patients in Western Australia: Retrospective Analysis of Population Based Registers. BMJ, 346, f2539.
https://doi.org/10.1136/bmj.f2539
|
[3]
|
Olfson, M., Gerhard, T., Huang, C., Crystal, S. and Stroup, T.S. (2015) Premature Mortality among Adults with Schizophrenia in the United States. JAMA Psychiatry, 72, 1172-1181. https://doi.org/10.1001/jamapsychiatry.2015.1737
|
[4]
|
Henderson, D.C., Vincenzi, B., Andrea, N.V., Ulloa, M. and Copeland, P.M. (2015) Pathophysiological Mechanisms of Increased Cardiometabolic Risk in People with Schizo-phrenia and Other Severe Mental Illnesses. The Lancet Psychiatry, 2, 452-464. https://doi.org/10.1016/S2215-0366(15)00115-7
|
[5]
|
Harris, L.W., Guest, P.C., Wayland, M.T., Umrania, Y., Krishnamurthy, D., Rahmoune, H. and Bahn, S. (2013) Schizophrenia: Metabolic Aspects of Aetiology, Diagnosis and Future Treatment Strategies. Psychoneuroendocrinology, 38, 752-766. https://doi.org/10.1016/j.psyneuen.2012.09.009
|
[6]
|
Foley, D.L. and Morley, K.I. (2011) Systematic Review of Early Cardiometabolic Outcomes of the First Treated Episode of Psychosis. Archives of General Psychiatry, 68, 609-616. https://doi.org/10.1001/archgenpsychiatry.2011.2
|
[7]
|
Lin, S.T., Chen, C.C., Tsang, H.Y., Lee, C.S., Yang, P., Cheng, K.D., Li, D.J., Wang, C.J., Hsieh, Y.C. and Yang, W.C. (2014) Association between Antipsychotic Use and Risk of Acute Myocardial Infarction: A Nationwide Case-Crossover Study. Circulation, 130, 235-243. https://doi.org/10.1161/CIRCULATIONAHA.114.008779
|
[8]
|
Wu, C.S., Tsai, Y.T. and Tsai, H.J. (2015) Anti-psychotic Drugs and the Risk of Ventricular Arrhythmia and/or Sudden Cardiac Death: A Nation-Wide Case-Crossover Study. Journal of the American Heart Association, 4, e001568.
https://doi.org/10.1161/JAHA.114.001568
|
[9]
|
García, S., Martínez-Cengotitabengoa, M., López-Zurbano, S., Zorrilla, I., López, P., Vieta, E. and González-Pinto, A. (2016) Adherence to Antipsychotic Medication in Bipolar Disor-der and Schizophrenic Patients: A Systematic Review. Journal of Clinical Psychopharmacology, 36, 355-371. https://doi.org/10.1097/JCP.0000000000000523
|
[10]
|
Bodén, R., Brandt, L., Kieler, H., Andersen, M. and Reutfors, J. (2011) Early Non-Adherence to Medication and Other Risk Factors for Rehospitalization in Schizophrenia and Schizoaffective Disorder. Schizophrenia Research, 133, 36-41.
https://doi.org/10.1016/j.schres.2011.08.024
|
[11]
|
Lester, H., Marshall, M., Jones, P., Fowler, D., Amos, T., Khan, N. and Birchwood, M. (2011) Views of Young People in Early Intervention Services for First-Episode Psychosis in England. Psychiatric Services, 62, 882-887.
https://doi.org/10.1176/ps.62.8.pss6208_0882
|
[12]
|
National Institute for Health and Care Excellence (2014) Psy-chosis and Schizophrenia in Adults: Prevention and Management. National Institute for Health and Care Excellence (UK), London.
|
[13]
|
National Clinical Guideline Centre (UK) (2014) National Institute for Health and Clinical Excellence: Guidance. In Obesity: Identification, Assessment and Management of Overweight and Obesity in Children, Young Peo-ple and Adults: Partial Update of CG43. National Institute for Health and Care Excellence (UK), London.
|
[14]
|
Bruins, J., Jörg, F., Bruggeman, R., Slooff, C., Corpeleijn, E. and Pijnenborg, M. (2014) The Effects of Lifestyle Interventions on (Long-Term) Weight Management, Cardiometabolic Risk and Depressive Symptoms in People with Psychotic Disorders: A Meta-Analysis. PLoS ONE, 9, e112276. https://doi.org/10.1016/j.schres.2012.03.017
|
[15]
|
Caemmerer, J., Cor-rell, C.U. and Maayan, L. (2012) Acute and Maintenance Effects of Non-Pharmacologic Interventions for Antipsychotic Associated Weight Gain and Metabolic Abnormalities: A Meta-Analytic Comparison of Randomized Controlled Trials. Schizophrenia Research, 140, 159-168. https://doi.org/10.1016/j.schres.2012.03.017
|
[16]
|
Panda, S. (2016) Circa-dian Physiology of Metabolism. Science, 354, 1008-1015.
https://doi.org/10.1126/science.aah4967
|
[17]
|
Chaix, A., Manoogian, E.N.C., Melkani, G.C. and Panda, S. (2019) Time-Restricted Eating to Prevent and Manage Chronic Metabolic Diseases. Annual Review of Nutrition, 39, 291-315.
https://doi.org/10.1146/annurev-nutr-082018-124320
|
[18]
|
Cienfuegos, S., Gabel, K., Kalam, F., Ezpeleta, M., Wiseman, E., Pavlou, V., Lin, S., Oliveira, M.L. and Varady, K.A. (2020) Effects of 4- and 6-h Time-Restricted Feeding on Weight and Cardiometabolic Health: A Randomized Controlled Trial in Adults with Obesity. Cell Metabolism, 32, 366-378.E3. https://doi.org/10.1016/j.cmet.2020.06.018
|
[19]
|
Longo, V.D. and Panda, S. (2016) Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan. Cell Metabolism, 23, 1048-1059. https://doi.org/10.1016/j.cmet.2016.06.001
|
[20]
|
Wu, X., Huang, Z., Wu, R., Zhong, Z., Wei, Q., Wang, H., Diao, F., Wang, J., Zheng, L., Zhao, J. and Zhang, J. (2013) The Comparison of Glycometabolism Parameters and Lipid Pro-files between Drug-Naïve, First-Episode Schizophrenia Patients and Healthy Controls. Schizophrenia Research, 150, 157-162. https://doi.org/10.1016/j.schres.2013.07.051
|
[21]
|
Enez Darcin, A., Yalcin Cavus, S., Dilbaz, N., Kaya, H. and Dogan, E. (2015) Metabolic Syndrome in Drug-Naïve and Drug-Free Patients with Schizophrenia and in Their Sib-lings. Schizophrenia Research, 166, 201-206.
https://doi.org/10.1016/j.schres.2015.05.004
|
[22]
|
Li, Z., Chen, J., Yu, H., He, L., Xu, Y., Zhang, D., Yi, Q., Li, C., Li, X., Shen, J., Song, Z., Ji, W., Wang, M., Zhou, J., Chen, B., Liu, Y., Wang, J., Wang, P., Yang, P., Wang, Q., Feng, G., Liu, B., Sun, W., Li, B., He, G., Li, W., Wan, C., Xu, Q., Li, W., Wen, Z., Liu, K., Huang, F., Ji, J., Ripke, S., Yue, W., Sullivan, P.F., O’Donovan, M.C. and Shi, Y. (2017) Genome-Wide Association Analysis Identifies 30 New Sus-ceptibility Loci for Schizophrenia. Nature Genetics, 49, 1576-1583. https://doi.org/10.1038/ng.3973
|
[23]
|
Stubbs, B., Vancampfort, D., De Hert, M. and Mitchell, A.J. (2015) The Prevalence and Predictors of Type Two Diabetes Melli-tus in People with Schizophrenia: A Systematic Review and Comparative Meta-Analysis. Acta Psychiatrica Scandinavica, 132, 144-157. https://doi.org/10.1111/acps.12439
|
[24]
|
Deng, C. (2013) Effects of Antipsychotic Medications on Appetite, Weight, and Insulin Resistance. Endocrinology and Metabolism Clinics of North America, 42, 545-563. https://doi.org/10.1016/j.ecl.2013.05.006
|
[25]
|
Milano, W., De Rosa, M., Milano, L. and Capasso, A. (2013) Anti-psychotic Drugs Opposite to Metabolic Risk: Neurotransmitters, Neurohormonal and Pharmacogenetic Mechanisms Un-derlying with Weight Gain and Metabolic Syndrome. The Open Neurology Journal, 7, 23-31. https://doi.org/10.2174/1874205X01307010023
|
[26]
|
Lord, C.C., Wyler, S.C., Wan, R., Castorena, C.M., Ahmed, N., Mathew, D., Lee, S., Liu, C. and Elmquist, J.K. (2017) The Atypical Antipsychotic Olanzapine Causes Weight Gain by Targeting Serotonin Receptor 2C. The Journal of Clinical Investigation, 127, 3402-3406. https://doi.org/10.1172/JCI93362
|
[27]
|
Kahn, R.S., Fleischhacker, W.W., Boter, H., Davidson, M., Vergouwe, Y., Keet, I.P., Gheorghe, M.D., Rybakowski, J.K., Galderisi, S., Libiger, J., Hummer, M., Dollfus, S., López-Ibor, J.J., Hranov, L.G., Gaebel, W., Peuskens, J., Lindefors, N., Riecher-Rössler, A. and Grobbee, D.E. (2008) Effectiveness of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: An Open Randomised Clinical Tri-al. The Lancet, 371, 1085-1097.
https://doi.org/10.1016/S0140-6736(08)60486-9
|
[28]
|
Mitchell, A.J., Vancampfort, D., De Herdt, A., Yu, W. and De Hert, M. (2013) Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizo-phrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients. Schizophrenia Bulletin, 39, 295-305. https://doi.org/10.1093/schbul/sbs082
|
[29]
|
Samson, S.L. and Garber, A.J. (2014) Metabolic Syndrome. Endocrinology and Metabolism Clinics of North America, 43, 1-23. https://doi.org/10.1016/j.ecl.2013.09.009
|
[30]
|
Freyberg, Z., Aslanoglou, D., Shah, R. and Ballon, J.S. (2017) In-trinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia. Frontiers in Neuroscience, 11, 432. https://doi.org/10.3389/fnins.2017.00432
|
[31]
|
Han, M., Deng, C., Burne, T.H., Newell, K.A. and Huang, X.F. (2008) Short- and Long-Term Effects of Antipsychotic Drug Treatment on Weight Gain and H1 Receptor Expression. Psychoneuroendocrinology, 33, 569-580.
https://doi.org/10.1016/j.psyneuen.2008.01.018
|
[32]
|
Kirk, S.L., Glazebrook, J., Grayson, B., Neill, J.C. and Reyn-olds, G.P. (2009) Olanzapine-Induced Weight Gain in the Rat: Role of 5-HT2C and Histamine H1 Receptors. Psycho-pharmacology (Berl), 207, 119-125.
https://doi.org/10.1007/s00213-009-1639-8
|
[33]
|
Matsui-Sakata, A., Ohtani, H. and Sawada, Y. (2005) Receptor Occupancy-Based Analysis of the Contributions of Various Receptors to Antipsychotics-Induced Weight Gain and Dia-betes Mellitus. Drug Metabolism and Pharmacokinetics, 20, 368-378. https://doi.org/10.2133/dmpk.20.368
|
[34]
|
Nasrallah, H.A. (2008) Atypical Antipsychotic-Induced Metabolic Side Effects: Insights from Receptor-Binding Profiles. Molecular Psychiatry, 13, 27-35. https://doi.org/10.1038/sj.mp.4002066
|
[35]
|
Schmidt, R.H., Jokinen, J.D., Massey, V.L., Falkner, K.C., Shi, X., Yin, X., Zhang, X., Beier, J.I. and Arteel, G.E. (2013) Olanzapine Activates Hepatic Mammalian Target of Rapamycin: New Mechanistic Insight into Metabolic Dysregulation with Atypical Antipsychotic Drugs. Journal of Pharmacology and Experimental Therapeutics, 347, 126-135. https://doi.org/10.1124/jpet.113.207621
|
[36]
|
Chen, J., Huang, X.F., Shao, R., Chen, C. and Deng, C. (2017) Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes. Frontiers in Neuroscience, 11, 643. https://doi.org/10.3389/fnins.2017.00643
|
[37]
|
Cox, A.J., West, N.P. and Cripps, A.W. (2015) Obesity, Inflammation, and the Gut Microbiota. The Lancet Diabetes & Endocrinology, 3, 207-215. https://doi.org/10.1016/S2213-8587(14)70134-2
|
[38]
|
Sung, M.M., Kim, T.T., Denou, E., Soltys, C.M., Hamza, S.M., Byrne, N.J., Masson, G., Park, H., Wishart, D.S., Madsen, K.L., Schertzer, J.D. and Dyck, J.R. (2017) Improved Glucose Homeostasis in Obese Mice Treated with Resveratrol Is Associated with Alterations in the Gut Microbiome. Diabetes, 66, 418-425.
https://doi.org/10.2337/db16-0680
|
[39]
|
Kanji, S., Fonseka, T.M., Marshe, V.S., Sriretnakumar, V., Hahn, M.K. and Müller, D.J. (2018) The Microbiome-Gut-Brain Axis: Implications for Schizophrenia and Antipsychotic Induced Weight Gain. European Archives of Psychiatry and Clinical Neuroscience, 268, 3-15. https://doi.org/10.1007/s00406-017-0820-z
|
[40]
|
Davey, K.J., Cotter, P.D., O’Sullivan, O., Crispie, F., Dinan, T.G., Cryan, J.F. and O’Mahony, S.M. (2013) Antipsychotics and the Gut Microbiome: Olanzapine-Induced Metabolic Dys-function Is Attenuated by Antibiotic Administration in the Rat. Translational Psychiatry, 3, e309. https://doi.org/10.1038/tp.2013.83
|
[41]
|
Bahr, S.M., Tyler, B.C., Wooldridge, N., Butcher, B.D., Burns, T.L., Teesch, L.M., Oltman, C.L., Azcarate-Peril, M.A., Kirby, J.R. and Calarge, C.A. (2015) Use of the Second-Generation Antipsychotic, Risperidone, and Secondary Weight Gain Are Associated with an Altered Gut Microbiota in Children. Translational Psychiatry, 5, e652.
https://doi.org/10.1038/tp.2015.135
|
[42]
|
Gabel, K. and Varady, K.A. (2020) Current Research: Effect of Time Re-stricted Eating on Weight and Cardiometabolic Health. The Journal of Physiology, Early View. https://doi.org/10.1113/JP280542
|
[43]
|
Gill, S. and Panda, S. (2015) A Smartphone App Reveals Erratic Diurnal Eating Patterns in Humans that Can Be Modulated for Health Benefits. Cell Metabolism, 22, 789-798. https://doi.org/10.1016/j.cmet.2015.09.005
|
[44]
|
Gabel, K., Hoddy, K.K., Haggerty, N., Song, J., Kroeger, C.M., Trepanowski, J.F., Panda, S. and Varady, K.A. (2018) Effects of 8-Hour Time Restricted Feeding on Body Weight and Metabolic Disease Risk Factors in Obese Adults: A Pilot Study. Nutrition and Healthy Aging, 4, 345-353. https://doi.org/10.3233/NHA-170036
|
[45]
|
Wilkinson, M.J., Manoogian, E.N.C., Zadourian, A., Lo, H., Fakhouri, S., Shoghi, A., Wang, X., Fleischer, J.G., Navlakha, S., Panda, S. and Taub, P.R. (2020) Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome. Cell Metabolism, 31, 92-104.E5.
https://doi.org/10.1016/j.cmet.2019.11.004
|
[46]
|
陈智远, 魏庆民, 刘亚玲, 等. 限时禁食法控制冠心病患者体重和血脂的临床研究[J]. 中国循证心血管医学杂志, 2020, 12(2): 217-220.
|
[47]
|
Moro, T., Tinsley, G., Bianco, A., Marcolin, G., Pacelli, Q.F., Battaglia, G., Palma, A., Gentil, P., Neri, M. and Paoli, A. (2016) Effects of Eight Weeks of Time-Restricted Feeding (16/8) on Basal Metabolism, Maximal Strength, Body Composition, Inflammation, and Cardio-vascular Risk Factors in Resistance-Trained Males. Journal of Translational Medicine, 14, Article No. 290. https://doi.org/10.1186/s12967-016-1044-0
|
[48]
|
Sutton, E.F., Beyl, R., Early, K.S., Cefalu, W.T., Ravussin, E. and Peterson, C.M. (2018) Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metabolism, 27, 1212-1221.e3. https://doi.org/10.1016/j.cmet.2018.04.010
|
[49]
|
Kesztyüs, D., Cermak, P., Gulich, M. and Kesztyüs, T. (2019) Adherence to Time-Restricted Feeding and Impact on Abdominal Obesity in Primary Care Patients: Results of a Pilot Study in a Pre-Post Design. Nutrients, 11, 2854
https://doi.org/10.3390/nu11122854
|
[50]
|
Mattson, M.P., Allison, D.B., Fontana, L., Harvie, M., Longo, V.D., Malaisse, W.J., Mosley, M., Notterpek, L., Ravussin, E., Scheer, F.A., Seyfried, T.N., Varady, K.A. and Panda, S. (2014) Meal Frequency and Timing in Health and Disease. Proceedings of the National Academy of Sciences of the United States of America, 111, 16647-16653.
https://doi.org/10.1073/pnas.1413965111
|
[51]
|
Gabel, K., Hoddy, K.K. and Varady, K.A. (2019) Safety of 8-h Time Restricted Feeding in Adults with Obesity. Applied Physiology, Nutrition, and Metabolism, 44, 107-109. https://doi.org/10.1139/apnm-2018-0389
|
[52]
|
Gabel, K., Hoddy, K.K., Burgess, H.J. and Varady, K.A. (2019) Ef-fect of 8-h Time-Restricted Feeding on Sleep Quality and Duration in Adults with Obesity. Applied Physiology, Nutrition, and Metabolism, 44, 903-906.
https://doi.org/10.1139/apnm-2019-0032
|
[53]
|
Wilhelmi de Toledo, F., Grundler, F., Bergouignan, A., Drinda, S. and Michalsen, A. (2019) Safety, Health Improvement and Well-Being during a 4 to 21-Day Fasting Period in an Obser-vational Study Including 1422 Subjects. PLoS One, 14, e0209353. https://doi.org/10.1371/journal.pone.0209353
|
[54]
|
Teruya, T., Chaleckis, R., Takada, J., Yanagida, M. and Kondoh, H. (2019) Diverse Metabolic Reactions Activated during 58-hr Fasting Are Revealed by Non-Targeted Metabolomic Analysis of Human Blood. Scientific Reports, 9, Article No. 854. https://doi.org/10.1038/s41598-018-36674-9
|
[55]
|
Sievert, K., Hussain, S.M., Page, M.J., Wang, Y., Hughes, H.J., Malek, M. and Cicuttini, F.M. (2019) Effect of Breakfast on Weight and Energy Intake: Systematic Review and Me-ta-Analysis of Randomised Controlled Trials. BMJ, 364, l42. https://doi.org/10.1136/bmj.l42
|
[56]
|
Potter, C., Griggs, R.L., Brunstrom, J.M. and Rogers, P.J. (2019) Breaking the Fast: Meal Patterns and Beliefs about Healthy Eat-ing Style Are Associated with Adherence to Intermittent Fasting Diets. Appetite, 133, 32-39.
https://doi.org/10.1016/j.appet.2018.10.020
|
[57]
|
Paoli, A., Tinsley, G., Bianco, A. and Moro, T. (2019) The Influ-ence of Meal Frequency and Timing on Health in Humans: The Role of Fasting. Nutrients, 11, 719. https://doi.org/10.3390/nu11040719
|
[58]
|
Mitchell, S.J., Bernier, M., Mattison, J.A., Aon, M.A., Kaiser, T.A., Anson, R.M., Ikeno, Y., Anderson, R.M., Ingram, D.K. and de Cabo, R. (2019) Daily Fasting Improves Health and Survival in Male Mice Independent of Diet Composition and Calories. Cell Metabolism, 29, 221-228.E3. https://doi.org/10.1016/j.cmet.2018.08.011
|
[59]
|
Anton, S.D., Moehl, K., Donahoo, W.T., Marosi, K., Lee, S. A., Mainous III, A.G., Leeuwenburgh, C. and Mattson, M.P. (2018) Flipping the Metabolic Switch: Understanding and Ap-plying the Health Benefits of Fasting. Obesity (Silver Spring), 26, 254-268. https://doi.org/10.1002/oby.22065
|
[60]
|
Di Francesco, A., Di Germanio, C., Bernier, M. and de Cabo, R. (2018) A Time to Fast. Science, 362, 770-775.
https://doi.org/10.1126/science.aau2095
|
[61]
|
Patterson, R.E. and Sears, D.D. (2017) Metabolic Effects of Intermit-tent Fasting. Annual Review of Nutrition, 37, 371-393. https://doi.org/10.1146/annurev-nutr-071816-064634
|
[62]
|
O’Neill, J.S. and Feeney, K.A. (2014) Circadian Redox and Metabolic Oscillations in Mammalian Systems. Antioxidants & Redox Signaling, 20, 2966-2981. https://doi.org/10.1089/ars.2013.5582
|
[63]
|
Paschos, G.K. and FitzGerald, G.A. (2017) Circadian Clocks and Me-tabolism: Implications for Microbiome and Aging. Trends in Genetics, 33, 760-769. https://doi.org/10.1016/j.tig.2017.07.010
|
[64]
|
Stenvers, D.J., Scheer, F., Schrauwen, P., la Fleur, S.E. and Kals-beek, A. (2019) Circadian Clocks and Insulin Resistance. Nature Reviews Endocrinology, 15, 75-89. https://doi.org/10.1038/s41574-018-0122-1
|
[65]
|
Rehan, L., Laszki-Szcząchor, K., Sobieszczańska, M. and Po-lak-Jonkisz, D. (2014) SIRT1 and NAD as Regulators of Ageing. Life Sciences, 105, 1-6. https://doi.org/10.1016/j.lfs.2014.03.015
|
[66]
|
Tippairote, T., Janssen, S. and Chunhabundit, R. (2020) Restoration of Metabolic Tempo through Time-Restricted Eating (TRE) as the Preventive Measure for Metabolic Diseases. Critical Reviews in Food Science and Nutrition, 1-10.
https://doi.org/10.1080/10408398.2020.1781050
|
[67]
|
Chaix, A. and Zarrinpar, A. (2015) The Effects of Time-Restricted Feeding on Lipid Metabolism and Adiposity. Adipocyte, 4, 319-324. https://doi.org/10.1080/21623945.2015.1025184
|
[68]
|
Zarrinpar, A., Chaix, A., Yooseph, S. and Panda, S. (2014) Diet and Feeding Pattern Affect the Diurnal Dynamics of the Gut Microbiome. Cell Metabolism, 20, 1006-1017. https://doi.org/10.1016/j.cmet.2014.11.008
|